BERTAGLIA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.188
EU - Europa 1.455
AS - Asia 1.138
SA - Sud America 80
OC - Oceania 61
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 4.942
Nazione #
US - Stati Uniti d'America 2.100
CN - Cina 534
IT - Italia 397
JP - Giappone 158
GB - Regno Unito 125
DE - Germania 122
FR - Francia 118
SE - Svezia 109
IE - Irlanda 106
SG - Singapore 99
AT - Austria 83
CA - Canada 72
UA - Ucraina 70
ES - Italia 66
IN - India 59
AU - Australia 55
HK - Hong Kong 51
VN - Vietnam 43
PL - Polonia 40
TW - Taiwan 39
FI - Finlandia 37
KR - Corea 35
NL - Olanda 33
BR - Brasile 28
GR - Grecia 28
ID - Indonesia 24
BE - Belgio 23
RU - Federazione Russa 17
CO - Colombia 16
TR - Turchia 16
CH - Svizzera 15
CL - Cile 15
MX - Messico 13
JO - Giordania 12
PT - Portogallo 12
TH - Thailandia 12
RO - Romania 10
HR - Croazia 9
PE - Perù 9
EC - Ecuador 8
EU - Europa 8
IL - Israele 8
LB - Libano 8
PH - Filippine 8
DK - Danimarca 7
PK - Pakistan 7
HU - Ungheria 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
EG - Egitto 4
IR - Iran 4
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
CZ - Repubblica Ceca 3
MO - Macao, regione amministrativa speciale della Cina 3
MY - Malesia 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AM - Armenia 2
KW - Kuwait 2
LT - Lituania 2
NG - Nigeria 2
RS - Serbia 2
SI - Slovenia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CG - Congo 1
CU - Cuba 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
PY - Paraguay 1
SA - Arabia Saudita 1
SN - Senegal 1
ZM - Zambia 1
Totale 4.942
Città #
Chandler 215
Fairfield 133
Beijing 122
Redwood City 113
Dublin 100
Houston 95
Wilmington 88
Ashburn 87
Singapore 74
Vienna 73
Woodbridge 71
Tokyo 66
Seattle 63
Nyköping 61
Shanghai 58
Torino 56
Turin 54
Guangzhou 50
Cambridge 48
Ann Arbor 44
Nanjing 36
Pisa 33
Dong Ket 32
Jacksonville 32
Villeurbanne 30
Chengdu 24
Columbus 24
Princeton 24
Medford 23
London 21
Milan 21
Jakarta 20
Taipei 20
Warsaw 20
Fremont 17
Wuhan 17
Toronto 16
Central 15
Athens 14
Boston 14
Helsinki 14
New York 14
Raritan 14
Dearborn 13
Hangzhou 13
Paris 13
Amman 12
Changsha 12
Québec 12
Seoul 12
Chicago 11
Munich 11
Central District 10
Duncan 10
Jinan 10
San Francisco 10
Santiago 10
Montréal 9
Shenyang 9
Brussels 8
Evanston 8
Rome 8
San Diego 8
Santa Clara 8
São Paulo 8
Vancouver 8
Berlin 7
Chongqing 7
Minneapolis 7
Sydney 7
Syracuse 7
Washington 7
Zhengzhou 7
Arlington 6
Barcelona 6
Bengaluru 6
El Segundo 6
Hefei 6
Karachi 6
Kunming 6
Lima 6
Madrid 6
Monash 6
Nanchang 6
Tianjin 6
Atlanta 5
Bangkok 5
Boardman 5
Bogotá 5
Brisbane 5
Gent 5
Hamburg 5
Lanzhou 5
Los Angeles 5
Montreal 5
Phoenix 5
Piemonte 5
Presidente Prudente 5
Richmond 5
Salt Lake City 5
Totale 2.595
Nome #
Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis 1.178
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer 1.172
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer 511
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome 277
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma 229
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 165
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 150
C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis 135
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival 110
Advanced squamous lung cancer: therapeutic options, future directions, unmet needs and results of a monocentric survey 110
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer 103
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 95
Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. 89
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel 85
Effects of Serum Testosterone Levels After 6 Months of Androgen Deprivation Therapy on the Outcome of Patients With Prostate Cancer. 84
PROGNOSTIC ROLE OF SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS DURING ANDROGEN-DEPRIVATION THERAPY 82
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era 77
Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?-a literature review 71
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center 52
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon 51
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer 48
Third line scenario in advanced non-small cell lung cancer: Is the anti-angiogenetic strategy the only actor up to now? 47
Oligoprogressive Disease With SCLC Transformation in EGFR-Mutated NSCLC: How Biology Knowledge Can Change the Game Rules 47
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center 33
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review 21
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience 21
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis 19
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review 15
Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors 12
null 7
Infections in lung cancer patients undergoing immunotherapy and targeted therapy: an overview on the current scenario 6
Totale 5.102
Categoria #
all - tutte 12.713
article - articoli 0
book - libri 0
conference - conferenze 564
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020530 0 0 0 0 51 92 81 62 100 46 52 46
2020/2021649 36 50 52 70 77 37 44 42 44 55 40 102
2021/2022607 46 41 39 50 47 30 47 45 38 51 119 54
2022/2023829 61 95 29 83 49 162 48 82 84 27 75 34
2023/2024484 62 72 29 46 40 41 8 37 10 41 58 40
2024/2025224 23 45 54 85 17 0 0 0 0 0 0 0
Totale 5.102